
Scan how Arteris' revenue guidance and ongoing losses compare with other high growth, higher risk opportunities by reviewing our hand picked 19 high quality undiscovered gems in similar territory.
To own Arteris, you need to believe its system IP can keep riding long running trends in AI, automotive and multi die chips while the company steadily closes the gap between fast revenue growth and persistent losses. The latest quarter shows that tradeoff clearly, with higher sales alongside a larger net loss and wider loss per share.
The analyst consensus narrative on Simply Wall St focuses on improving operating discipline over time, so the raised full year revenue guidance and specific Q4 outlook matter as a near term proof point. The main short term catalyst remains execution on that contract base. The biggest risk is that operating losses stay elevated if costs or lower margin work offset the higher top line.
The most relevant update here is Arteris guiding Q4 2026 revenue to US$25.7 million to US$26.7 million and lifting full year guidance to US$98.5 million to US$99.5 million. That sits alongside nine month revenue of US$72.84 million and a reported net loss of US$33.18 million, with a basic loss per share of US$0.70.
For you as an investor, this pairing of firmer near term revenue expectations with continued GAAP losses goes straight to the core thesis. Execution on AI, automotive and hardware security demand can act as a catalyst if it supports future royalty streams and operating leverage. The risk side is clear too, as any slowdown in that growth path could leave Arteris carrying sizeable losses for longer.
Arteris' narrative projects US$162.9 million revenue and US$20.1 million earnings by 2029. This requires 24.4% yearly revenue growth and an earnings increase of about US$59.6 million from current earnings of a US$39.5 million loss.
Uncover how Arteris' fair value points to a 83% potential upside to its current price, which could narrow quickly as expectations reset.
One optimistic angle on Arteris leans hard into the royalty story. The most bullish analysts were pencilling in US$195.8 million of revenue and US$18.2 million of earnings by 2029 before this Q3 update. You can treat the raised 2026 guidance as a fresh data point and then test whether that upbeat path still feels reasonable to you.
Explore 3 other Arteris fair value estimates, including one that suggests up to 307% upside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your own analysis and judgment.
If Arteris has sharpened your sense of what high growth and higher risk can look like, it can help to line that up against other opportunities that fit very different profiles on value, quality and resilience.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com